Efavirenz Tablet
Product Images NDC 33342-013

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 33342-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Efavirenz-structure (Efavirenz Structure)

Chemical structure of Efavirenz, showing its molecular configuration including chlorine, trifluoromethyl group, and cyclopropylethynyl moieties.*

FDA Label Image

30 (Efavirenz Tab 600 mg)

Label for Efavirenz Tablets, USP 600 mg oral tablets produced by Macleods Pharmaceuticals Limited. The label includes dosage strength, manufacturer details (Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.), and storage instructions. It also contains a warning alert about medicines that should not be taken with Efavirenz and indicates the package contains 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.